Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin Wan

Showing results (431-440 of 443) with videos related to

Pageof 45
Sort By:
Nature Genetics|December 27, 2011
A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathyXue-Qing Yu, Ming Li, Hong Zhang, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2020
Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA NephropathyMing Li, Ling Wang, Dian-Chun Shi, et al.
Frontiers in Pharmacology|August 13, 2024
Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)Nan Shen, Lihong Zhang, Jing Yang, et al.
Frontiers in Pharmacology|October 16, 2024
Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)Nan Shen, Lihong Zhang, Jing Yang, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Frontiers in Pharmacology|June 1, 2026
Safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate for hyperkalemia management in China: actualize studyNan Shen, Xin Zeng, Hua Xie, et al.
Virologica Sinica|April 9, 2021
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human PrimatesYan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, et al.
Frontiers in Immunology|July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 TrialShengli Xia, Kai Duan, Yuntao Zhang, et al.
Eclinicalmedicine|July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialWanshen Guo, Kai Duan, Yuntao Zhang, et al.
BMJ Open|March 8, 2023
Evaluation of safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate in management of hyperkalaemia in China: a real-world study protocolNan Shen, Qingyang Meng, Lihong Zhang, et al.
Pageof 45

Showing results (431-440 of 443) with videos related to

Sort By:
Pageof 45
Nature Genetics|December 27, 2011
A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathyXue-Qing Yu, Ming Li, Hong Zhang, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2020
Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA NephropathyMing Li, Ling Wang, Dian-Chun Shi, et al.
Frontiers in Pharmacology|August 13, 2024
Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)Nan Shen, Lihong Zhang, Jing Yang, et al.
Frontiers in Pharmacology|October 16, 2024
Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)Nan Shen, Lihong Zhang, Jing Yang, et al.
JAMA|August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsShengli Xia, Kai Duan, Yuntao Zhang, et al.
Frontiers in Pharmacology|June 1, 2026
Safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate for hyperkalemia management in China: actualize studyNan Shen, Xin Zeng, Hua Xie, et al.
Virologica Sinica|April 9, 2021
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human PrimatesYan-Feng Yao, Ze-Jun Wang, Ren-Di Jiang, et al.
Frontiers in Immunology|July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 TrialShengli Xia, Kai Duan, Yuntao Zhang, et al.
Eclinicalmedicine|July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trialWanshen Guo, Kai Duan, Yuntao Zhang, et al.
BMJ Open|March 8, 2023
Evaluation of safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate in management of hyperkalaemia in China: a real-world study protocolNan Shen, Qingyang Meng, Lihong Zhang, et al.
Pageof 45